News
Article
Author(s):
Dermatology Times is recapping our top expert interviews from the month of February.
The conference's course directors give a sneak peek of what in-person and virtual attendees will learn about AI, alternative medicine, surgical management of HS, and more.
Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Shanna Miranti, MPAS, PA-C, shares updates on the status of roflumilast foam 0.3% and Cabtreo available in US pharmacies.
The Skin Cancer Foundation’s initiative, Destination Healthy Skin, travels to various cities throughout the country in an RV, wherein volunteer dermatologists provide on-the-street, free-of-cost skin screenings.
Alongside expert dermatologists, the NRS recently developed a Seal of Acceptance for skin care and cosmetic products clinically tested and evaluated for patients with rosacea.
In an interview with Dermatology Times, the executive director of Pediatric Dermatology Research Alliance (PeDRA) discusses the group's growth since 2012 and what it can offer practicing dermatologists, researchers, students, and patients.
Learn what makes the Masterclasses in Dermatology conference a unique educational opportunity, and take a quick poll to tell us what you want to learn.
Alice Gottlieb, MD, PhD, put a spotlight on recent studies and the current psoriasis treatment armamentarium for dermatology clinicians to consider.
AI's transformative impact on medicine, explored by Ryan Stidham, MD, reveals potential applications in dermatology, emphasizing caution, ethical considerations, and the need for collaboration across specialties.
Discover the evolving landscape of lupus treatment, from the importance of monitoring vitamin D levels to advancements in emerging therapies targeting type 1 interferon and plasmacytoid dendritic cells.
Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.
Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
Miller, Vice President, Immunodermatology Disease Area Leader, Johnson & Johnson, spoke with Dermatology Times about recently published data supporting JNJ-2113's potential in this indication.
Barbieri spoke with Dermatology Times to discuss the new guidelines and the recommendations and good practice statements included.
Shawn Kwatra, MD, shares insights into neuropathic pruritus’ debilitating effects on patients and how clinicians can use unified nomenclature.
Miranda Uzoma Ewelukwa, MD, FAAD, reviews how skin of color representation has evolved in dermatology, however, more advocacy is still needed.
Platelet-rich plasma (PRP) holds great promise for regenerative hair and skin applications, but trials, standards, and protocols are needed, one review has found.
Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.